CIK: 0001306923 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 15, 2024
Total Value ($000): $1,109,908 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 5,511,721 | $170,808 | 15.4% | $17.79 | +45.8% | COM PAR $.01 | 457669307 |
| FOLD | AMICUS THERAPEUTICS INC | 10,373,715 | $147,203 | 13.3% | $9.63 | +18.0% | COM | 03152W109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,500,749 | $144,702 | 13.0% | $83.16 | +6.4% | COM | 09061G101 |
| BIIB | BIOGEN INC | 380,417 | $98,441 | 8.9% | $264.98 | -7.3% | COM | 09062X103 |
| UTHR | UNITED THERAPEUTICS CORP | 395,784 | $87,029 | 7.8% | $89.23 | +158.3% | COM | 91307C102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,409,556 | $75,443 | 6.8% | $28.41 | -15.9% | COM | 004225108 |
| PRTA | PROTHENA CORP PLC | 1,660,057 | $60,326 | 5.4% | $21.46 | +79.4% | SHS | G72800108 |
| — | REVANCE THERAPEUTICS INC | 5,237,284 | $46,036 | 4.1% | $21.40 | — | COM | 761330109 |
| STAA | STAAR SURGICAL CO | 1,376,950 | $42,975 | 3.9% | $24.23 | +48.3% | COM PAR $0.01 | 852312305 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 154,437 | $29,561 | 2.7% | $170.34 | 0.0% | COM | 02043Q107 |
| EHTH | EHEALTH INC | 2,739,379 | $23,887 | 2.2% | $38.13 | -78.6% | COM | 28238P109 |
| — | SAGE THERAPEUTICS INC | 991,525 | $21,486 | 1.9% | $42.84 | — | COM | 78667J108 |
| SRPT | SAREPTA THERAPEUTICS INC | 200,905 | $19,373 | 1.7% | $111.32 | -13.8% | COM | 803607100 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 2,106,792 | $17,128 | 1.5% | $5.23 | 0.0% | COM | 462260100 |
| ALKS | ALKERMES PLC | 603,400 | $16,738 | 1.5% | $22.36 | +16.2% | SHS | G01767105 |
| — | NEVRO CORP | 750,371 | $16,148 | 1.5% | $21.87 | — | COM | 64157F103 |
| ALGN | ALIGN TECHNOLOGY INC | 55,705 | $15,263 | 1.4% | $149.18 | +58.9% | COM | 016255101 |
| ANAB | ANAPTYSBIO INC | 686,882 | $14,713 | 1.3% | $18.38 | -6.2% | COM | 032724106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 472,600 | $10,213 | 0.9% | $16.84 | -8.7% | COM | 87164F105 |
| CYTK | CYTOKINETICS INC | 111,717 | $9,327 | 0.8% | $6.71 | +439.4% | COM NEW | 23282W605 |
| NVCR | NOVOCURE LTD | 561,908 | $8,389 | 0.8% | $58.84 | -77.3% | ORD SHS | G6674U108 |
| — | VERVE THERAPEUTICS INC | 575,817 | $8,027 | 0.7% | $13.94 | — | COM | 92539P101 |
| GOSS | GOSSAMER BIO INC | 5,958,888 | $6,530 | 0.6% | $1.61 | -54.2% | COM | 38341P102 |
| — | BLUEBIRD BIO INC | 3,333,333 | $4,600 | 0.4% | $1.38 | — | COM | 09609G100 |
| — | KARYOPHARM THERAPEUTICS INC | 5,102,193 | $4,413 | 0.4% | $16.36 | — | COM | 48576U106 |
| RLMD | RELMADA THERAPEUTICS INC | 732,400 | $3,032 | 0.3% | $3.27 | -9.5% | COM | 75955J402 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1,910 | 0.2% | $15.56 | +94.5% | COM | 604749101 |
| VNDA | VANDA PHARMACEUTICALS INC | 278,985 | $1,177 | 0.1% | $11.21 | -64.0% | COM | 921659108 |
| VYNE | VYNE THERAPEUTICS INC PIPE | 445,434 | $1,038 | 0.1% | $3.12 | 0.0% | COM | 92941V308 |
| TVTX | TRAVERE THERAPEUTICS INC | 110,719 | $995 | 0.1% | $23.56 | -69.1% | COM | 89422G107 |
| TSHA | TAYSHA GENE THERAPIES INC | 529,861 | $938 | 0.1% | $1.99 | 0.0% | COM SHS | 877619106 |
| SGHT | SIGHT SCIENCES INC | 173,790 | $897 | 0.1% | $3.09 | 0.0% | COM | 82657M105 |
| ALDX | ALDEYRA THERAPEUTICS INC | 225,465 | $791 | 0.1% | $5.95 | -48.1% | COM | 01438T106 |
| URGN | UROGEN PHARMA LTD | 24,500 | $368 | 0.0% | $27.01 | -51.9% | COM | M96088105 |